Studying Health Outcomes After Treatment in Patients With Retinoblastoma

Clinical trial NCT03932786 · RECRUITING

Trial details

NCT number: NCT03932786
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Study type: OBSERVATIONAL

Retinoblastoma Cancer Survivor Biological Sibling Intraocular Retinoblastoma Unilateral Retinoblastoma

Start date: 2019-01-24
Primary completion: 2030-01-01
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.